[1] Wilke TJ, Fremming BA, Brown BA, et al. 2020 Clinical update in liver transplantation. J Cardiothorac Vasc Anesth, 2022,36(5): 1449-1457. [2] 中华医学会器官移植学分会. 中国儿童肝移植麻醉技术操作规范(2019版). 中华移植杂志(电子版), 2020,14(2): 65-71. [3] 杨璐, 姚永兴. 成人肝脏移植围术期麻醉管理专家共识. 临床麻醉学杂志, 2020,36(05): 499-506. [4] 俞卫锋, 黄文起, 杨立群. 小儿肝移植术麻醉管理专家共识. 临床麻醉学杂志, 2021,37(04): 424-429. [5] Moller S, Bendtsen F, Henriksen JH. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scand J Gastroenterol, 2005,40(5): 491-500. [6] Moller S, Danielsen KV, Wiese S, et al. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol, 2019,13(5): 497-505. [7] Krowka MJ, Fallon MB, Kawut SM, et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation, 2016,100(7): 1440-1452. [8] Hemprich U, Papadakos PJ, Lachmann B. Respiratory failure and hypoxemia in the cirrhotic patient including hepatopulmonary syndrome. Curr Opin Anaesthesiol, 2010,23(2): 133-138. [9] Lisman T, Violi F. Cirrhosis as a risk factor for venous thrombosis. Thromb Haemost, 2017,117(1): 3-5. [10] De Pietri L, Montalti R, Nicolini D, et al. Perioperative thromboprophylaxis in liver transplant patients. World J Gastroenterol, 2018,24(27): 2931-2948. [11] Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant, 2008,13(3): 298-303. [12] Critelli K, Mckiernan P, Vockley J, et al. Liver transplantation for propionic acidemia and methylmalonic acidemia: perioperative management and clinical outcomes. Liver Transpl, 2018,24(9): 1260-1270. [13] Yoo, Lee J, Lee et al. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: A Retrospective Observational Study. Anesth Analg, 2017,124(1): 35-41. [14] 刘杨, 熊利泽. 围术期医学是麻醉学的发展方向. 中华麻醉学杂志, 2016,36(1): 3-4. [15] 中国医疗保健国际交流促进会围术期医学分会. 学转变. 中华麻醉学杂志, 2020,40(11): 1309-1312. |